SUT Rocking Bioreactors Market Size, Share, and Industry Analysis, By Capacity (1L - 25L, 26L - 100L, and More than 100L), By Application (Cell Culture Processes, Fermentation Processes, and Others), By End User (Biopharmaceutical/Pharmaceutical Companies, Contract Manufacturing Organizations & Contract Research Organizations, and Others), and Regional Forecast, 2024-2032

A bioreactor is referred to as a vessel or a system that converts raw materials into products by using microbial, plant, animal, or human cells. This device provides a biologically active environment for the cell culture to support efficient cell growth. The main types of bioreactors include rocking bioreactors, stirred-tank bioreactors, and fixed-bed bioreactors.

Rocking bioreactors are devices that are installed with a motorized base to generate a mild rocking motion. This motion creates waves in the cell culture media for effective mixing and gas transfer for respiring cells. Rocking bioreactors are made up of different components, such as a rocker system for motion, software for the initiation of the cell culture processes, single-use bag bioreactor containers, and PVC tubing. Furthermore, the rocking angle and the speed of these devices are adjustable to match the needs of the different cell types. Rocking motion bioreactors create the culture of different types of cells, including insects, plants, mammalian cells, and the Chinese hamster ovary (CHO) cells.

In addition, the rocking motion bioreactors can be used to produce vaccines and recombinant proteins, with advanced control strategies enabling high cell densities and protein expression for microbial cultivation. The growth of the market is mainly attributed to the fact that rocking bioreactors offer several advantages as they provide stability and efficiency for differentiating pluripotent stem cell aggregates and maintaining high viability and pluripotency.

The COVID-19 pandemic had a positive impact on the SUT rocking bioreactors market in 2020. The market witnessed an increase in the adoption of single-use rocking bioreactors during the pandemic. The pandemic hastened the adoption of single-use solutions, including rocking bioreactors, to fulfill the technological requirements for the research and development of biopharmaceuticals and vaccines.

• For instance, as per the data provided by Elsevier Ltd. in March 2024, the widespread use of disposable rocking bioreactors for the large-scale production of biotic agents for vaccines during the COVID-19 pandemic confirmed their practical applicability in the biopharmaceutical industry.

Therefore, the market growth was greatly enhanced by an increase in the adoption of single-use rocking bioreactors during the pandemic.

Segmentation

Key Insights

The following key insights are covered in the report:

• Overview: Technological Advancements in SUT Rocking Bioreactors


• New Product Launches, By Key Players


• Key Industry Developments (Mergers, Acquisitions, and Partnerships)


• Impact of COVID-19 on the Global SUT Rocking Bioreactors Market

Analysis by Application

Based on the application, the market can be segmented into cell culture processes, fermentation processes, and others.

The cell culture processes segment is anticipated to hold a significant market share throughout the forecast period due to the growing use of cell cultures to develop vaccines. Also, the growth of the segment is mainly driven by the increasing use of cell cultures for studying the interaction of drugs with cells and the production of recombinant proteins.

• For instance, as per the data provided by the PLOS in June 2023, a research study was conducted by some of the researchers of Amgen Inc. for the production of recombinant protein from the Human Embryonic Kidney (HEK) 293 cell line.

Therefore, the market growth is expected to be driven by an increased use of rocking bioreactors in the development of viral vaccines during the forecast period.

Moreover, the fermentation processes segment is projected to grow at a substantial CAGR during the forecast period. The growth of the segment is mainly due to the fact that several industry players and research organizations are involved in the development of antiviral medications, monoclonal antibodies, and therapeutic recombinant proteins.

Regional Analysis

Based on the region, the SUT rocking bioreactors market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

The market in North America is expected to grow at a significant CAGR throughout the forecast period. Increasing demand by biopharmaceutical companies for efficient bioreactors and the strong presence of market players, such as Cytiva and Thermo Fisher Scientific Inc., in the region are responsible for the market's growth.

Furthermore, Asia Pacific accounted for a considerable market share in 2023. The regional growth is primarily attributed to the increasing research and development activities for the development of viral vaccines with the help of the rocking bioreactor systems. Also, the launch of rocking bioreactors by key players in the region is one of the factors accountable for the growth of the market in the Asia Pacific region.

• For instance, in March 2024, Beijing CytoNiche Biotechnology Co., Ltd. announced the launch of a 3D FloTrix vivaROCK Bioreactor System in the Chinese market.

Key Players Covered

The report includes the profiles of key players, such as Cytiva, PROAnalytics, LLC, Bionet, Thermo Fisher Scientific Inc., and Sartorius AG.

Key Industry Developments

• In December 2020, Celltainer, a subsidiary of Bionet, announced its new collaboration with Penn State University. As per the collaboration, the company's 20 Liter CELL-trainer two-dimensional single-use rocker bioreactor was used in the R&D studies by Penn State University.


• In June 2019, Sartorius AG announced the launch of its novel Ambr 250 modular bioreactor vessel for cell and gene therapy applications.


• In January 2019, Sartorius AG launched the BIOSTAT RM TX single-use bioreactor, a novel wave-mixed system for developing vaccines and biologics.